6/17/24 19:21 | 6/13/24 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moyes Jay M | CA | D | | S | -73 | 3.34 | 0 | -22 | -51 | 21 | D | | | | | | | | | | | | | | |
6/15/23 21:10 | 6/13/23 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moyes Jay M | CA | D | | S | -76 | 3.45 | 0 | -22 | -34 | 43 | D | | | | | | | | | | | | | | |
6/21/22 19:05 | 6/16/22 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moyes Jay M | CA | D | | S | -60 | 2.64 | 0 | -23 | -37 | 38 | D | | | | | | | | | | | | | | |
6/11/21 17:36 | 6/10/21 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moyes Jay M | CA | D | | S | -287 | 11.36 | 0 | -25 | -80 | 6 | D | | | | | | | | | | | | | | |
9/17/20 17:18 | 9/16/20 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moyes Jay M | CA | D | | S | -97 | 10.00 | 0 | -10 | -24 | 32 | D | | | | | | | | | | | | | | |
6/17/20 19:47 | 6/16/20 | PBYI | Puma Biotechnology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moyes Jay M | CA | D | | S | -92 | 9.50 | 0 | -10 | -19 | 41 | D | | | | | | | | | | | | | | |
8/23/19 06:24 | 7/26/19 | BCDA | Biocardia, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Moyes Jay M | CA | D | | M.d | 0 | 0.00 | 0 | 4 | 979 | 4 | D | | | | | | | | | | | | | | |
10/16/07 16:51 | 10/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M.d | 126 | 12.54 | 33 | 10 | 64 | 26 | D | 174 | 113 | 52 | 41 | 24 | 10 | -1 | -5 | -3 | -5 | -11 | -14 | -23 | 5 |
10/16/07 16:51 | 10/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S.d | -553 | 55.11 | 33 | -10 | -28 | 26 | D | 174 | 113 | 52 | 41 | 24 | 10 | -1 | -5 | -3 | -5 | -11 | -14 | -23 | 5 |
10/16/07 16:51 | 10/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M | 59 | 12.54 | 33 | 5 | 23 | 25 | D | 174 | 113 | 52 | 41 | 24 | 10 | -1 | -5 | -3 | -5 | -11 | -14 | -23 | 5 |
10/16/07 16:51 | 10/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S | -260 | 55.50 | 33 | -5 | -16 | 25 | D | 174 | 113 | 52 | 41 | 24 | 10 | -1 | -5 | -3 | -5 | -11 | -14 | -23 | 5 |
10/16/07 16:51 | 10/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M | 74 | 12.54 | 33 | 6 | 31 | 25 | D | 174 | 113 | 52 | 41 | 24 | 10 | -1 | -5 | -3 | -5 | -11 | -14 | -23 | 5 |
10/16/07 16:51 | 10/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S | -327 | 55.20 | 33 | -6 | -19 | 25 | D | 174 | 113 | 52 | 41 | 24 | 10 | -1 | -5 | -3 | -5 | -11 | -14 | -23 | 5 |
10/16/07 16:50 | 10/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M | 124 | 12.54 | 33 | 10 | 64 | 25 | D | 174 | 113 | 52 | 41 | 24 | 10 | -1 | -5 | -3 | -5 | -11 | -14 | -23 | 5 |
10/16/07 16:50 | 10/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S | -543 | 55.05 | 33 | -10 | -28 | 25 | D | 174 | 113 | 52 | 41 | 24 | 10 | -1 | -5 | -3 | -5 | -11 | -14 | -23 | 5 |
10/16/07 16:50 | 10/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M | 113 | 12.54 | 33 | 9 | 55 | 25 | D | 174 | 113 | 52 | 41 | 24 | 10 | -1 | -5 | -3 | -5 | -11 | -14 | -23 | 5 |
10/16/07 16:50 | 10/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S | -493 | 54.75 | 33 | -9 | -26 | 25 | D | 174 | 113 | 52 | 41 | 24 | 10 | -1 | -5 | -3 | -5 | -11 | -14 | -23 | 5 |
9/14/07 19:08 | 9/13/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M.d | 5 | 10.74 | 33 | 0 | 2 | 26 | D | 127 | 91 | 47 | 26 | 26 | 10 | 6 | 3 | -2 | -2 | 16 | 1 | -24 | 39 |
9/14/07 19:08 | 9/13/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S.d | -22 | 47.22 | 33 | 0 | -2 | 26 | D | 127 | 91 | 47 | 26 | 26 | 10 | 6 | 3 | -2 | -2 | 16 | 1 | -24 | 39 |
9/14/07 19:08 | 9/13/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M | 99 | 6.86 | 33 | 14 | 134 | 25 | D | 127 | 91 | 47 | 26 | 26 | 10 | 6 | 3 | -2 | -2 | 16 | 1 | -24 | 39 |
9/14/07 19:08 | 9/13/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S | -685 | 47.30 | 33 | -14 | -36 | 25 | D | 127 | 91 | 47 | 26 | 26 | 10 | 6 | 3 | -2 | -2 | 16 | 1 | -24 | 39 |
9/14/07 19:08 | 9/13/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M | 86 | 7.02 | 33 | 12 | 94 | 25 | D | 127 | 91 | 47 | 26 | 26 | 10 | 6 | 3 | -2 | -2 | 16 | 1 | -24 | 39 |
9/14/07 19:08 | 9/13/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S | -579 | 47.33 | 33 | -12 | -33 | 25 | D | 127 | 91 | 47 | 26 | 26 | 10 | 6 | 3 | -2 | -2 | 16 | 1 | -24 | 39 |
9/14/07 19:08 | 9/13/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M | 286 | 10.16 | 33 | 28 | | 25 | D | 127 | 91 | 47 | 26 | 26 | 10 | 6 | 3 | -2 | -2 | 16 | 1 | -24 | 39 |
9/14/07 19:08 | 9/13/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S | -1,331 | 47.21 | 33 | -28 | -53 | 25 | D | 127 | 91 | 47 | 26 | 26 | 10 | 6 | 3 | -2 | -2 | 16 | 1 | -24 | 39 |
9/14/07 19:07 | 9/12/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M.m | 173 | 6.93 | 33 | 25 | 999% | 25 | D | 127 | 91 | 47 | 26 | 26 | 10 | 6 | 3 | -2 | -2 | 16 | 1 | -24 | 39 |
9/14/07 19:07 | 9/12/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S.m | -1,176 | 47.24 | 33 | -25 | -50 | 25 | D | 127 | 91 | 47 | 26 | 26 | 10 | 6 | 3 | -2 | -2 | 16 | 1 | -24 | 39 |
6/18/07 17:46 | 6/15/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S | -57 | 37.73 | 33 | -2 | -6 | 26 | D | 146 | 64 | 23 | 18 | -4 | -2 | 1 | 5 | -1 | -5 | 3 | 23 | 21 | 19 |
2/26/07 13:10 | 2/5/07 | OSIR | Osiris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Moyes Jay M | MD | D | | M | 35 | 23.62 | 5 | 2 | New | 2 | D | | | 60 | -21 | -40 | -27 | -13 | -10 | 2 | -14 | 29 | -20 | -23 | -26 |
1/11/07 17:29 | 1/9/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M.d | 111 | 13.56 | 32 | 8 | 44 | 27 | D | 49 | 51 | 33 | 28 | 11 | 6 | 5 | 4 | 3 | 3 | 6 | 4 | 17 | 44 |
1/11/07 17:29 | 1/9/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S.d | -265 | 32.50 | 32 | -8 | -23 | 27 | D | 49 | 51 | 33 | 28 | 11 | 6 | 5 | 4 | 3 | 3 | 6 | 4 | 17 | 44 |
11/20/06 13:54 | 11/16/06 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M.dm | 111 | 13.56 | 23 | 8 | 45 | 26 | D | 55 | 57 | 22 | 14 | 17 | 11 | 11 | 4 | 0 | -1 | 3 | 16 | 32 | 54 |
11/20/06 13:54 | 11/16/06 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S.dm | -245 | 30.00 | 23 | -8 | -24 | 26 | D | 55 | 57 | 22 | 14 | 17 | 11 | 11 | 4 | 0 | -1 | 3 | 16 | 32 | 54 |
10/18/06 11:54 | 10/18/06 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S | -135 | 27.08 | 18 | -5 | -16 | 26 | D | 52 | 30 | 3 | 13 | 9 | 10 | 4 | 3 | 1 | 1 | 11 | 35 | 34 | 95 |
6/13/06 18:36 | 6/13/06 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M.d | 191 | 12.38 | 20 | 15 | 104 | 30 | C | | | | | | | | | 1 | 0 | 5 | 6 | 37 | 60 |
2/27/06 18:20 | 2/27/06 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M.d | 36 | 12.38 | 20 | 3 | 24 | 15 | C | | | | | | | | | 0 | 2 | 1 | -2 | -4 | 33 |
2/27/06 18:20 | 2/27/06 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S.d | -73 | 25.21 | 20 | -3 | -16 | 15 | C | | | | | | | | | 0 | 2 | 1 | -2 | -4 | 33 |
2/14/06 18:52 | 2/10/06 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | M.d | 155 | 12.38 | 19 | 13 | 543 | 15 | C | | | | | | | | | 2 | 0 | 15 | 9 | 5 | 47 |
2/14/06 18:52 | 2/10/06 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S.d | -314 | 25.03 | 19 | -13 | -46 | 15 | C | | | | | | | | | 2 | 0 | 15 | 9 | 5 | 47 |
12/21/05 12:13 | 12/21/05 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | CFO | S | -49 | 19.98 | 15 | -2 | -14 | 15 | D | 61 | -10 | 21 | 0 | 5 | 3 | -1 | -4 | 3 | 6 | 9 | 29 | 18 | 58 |
6/9/05 18:39 | 6/9/05 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Moyes Jay M | UT | O | VP Finan | M.d | 19 | 3.50 | 11 | 6 | 52 | 16 | D | -3 | 0 | -27 | -27 | -11 | -13 | -10 | -4 | 1 | -2 | 14 | 31 | 28 | 65 |